AAAAAA

   
Results: 1-7 |
Results: 7
A SOLUBLE CHIMERIC C3-CONVERTASE, C5-CONVERTASE INHIBITOR CAN PROLONGXENOGRAFT SURVIVAL IN PIG-TO-PRIMATE CARDIAC TRANSPLANTATION
Authors: SALERNO CT DALMASSO AP KULICK DM GUZMAN M YEH CG HIGGINS PJ BOLMAN RM
Citation: Ct. Salerno et al., A SOLUBLE CHIMERIC C3-CONVERTASE, C5-CONVERTASE INHIBITOR CAN PROLONGXENOGRAFT SURVIVAL IN PIG-TO-PRIMATE CARDIAC TRANSPLANTATION, Molecular immunology, 35(6-7), 1998, pp. 45-45
(+ LPHENYL]-5-(3,4,5-TRIMETHOXYPHENYL)TETRAHYDROFURAN (CMI-392), A POTENT DUAL 5-LIPOXYGENASE INHIBITOR AND PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST/
Authors: CAI XO SCANNELL RT YAEGER D HUSSOIN MS KILLIAN DB QIAN CG ECKMAN J HWANG SB LIBERTINEGARAHAN L YEH CG IP SH SHEN TY
Citation: Xo. Cai et al., (+ LPHENYL]-5-(3,4,5-TRIMETHOXYPHENYL)TETRAHYDROFURAN (CMI-392), A POTENT DUAL 5-LIPOXYGENASE INHIBITOR AND PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST/, Journal of medicinal chemistry, 41(11), 1998, pp. 1970-1979
C3-CONVERTASE AND C5-CONVERTASE INHIBITION PREVENTS MONOCYTE AND PMN ACTIVATION DURING IN-VITRO CARDIOPULMONARY BYPASS
Authors: LEE D SMITH MJ TRACEY JB JOHNSON K HIGGINS P YEH CG SMITH BR RINDER CS
Citation: D. Lee et al., C3-CONVERTASE AND C5-CONVERTASE INHIBITION PREVENTS MONOCYTE AND PMN ACTIVATION DURING IN-VITRO CARDIOPULMONARY BYPASS, Anesthesia and analgesia, 86(4), 1998, pp. 1-1
A SOLUBLE CHIMERIC COMPLEMENT INHIBITORY PROTEIN THAT POSSESSES BOTH DECAY-ACCELERATING AND FACTOR-I COFACTOR ACTIVITIES
Authors: HIGGINS PJ KO JL LOBELL R SARDONINI C ALESSI MK YEH CG
Citation: Pj. Higgins et al., A SOLUBLE CHIMERIC COMPLEMENT INHIBITORY PROTEIN THAT POSSESSES BOTH DECAY-ACCELERATING AND FACTOR-I COFACTOR ACTIVITIES, The Journal of immunology, 158(6), 1997, pp. 2872-2881
THE EFFECTS OF SOLUBLE RECOMBINANT COMPLEMENT RECEPTOR-1 ON COMPLEMENT-MEDIATED EXPERIMENTAL GLOMERULONEPHRITIS
Authors: COUSER WG JOHNSON RJ YOUNG BA YEH CG TOTH CA RUDOLPH AR
Citation: Wg. Couser et al., THE EFFECTS OF SOLUBLE RECOMBINANT COMPLEMENT RECEPTOR-1 ON COMPLEMENT-MEDIATED EXPERIMENTAL GLOMERULONEPHRITIS, Journal of the American Society of Nephrology, 5(11), 1995, pp. 1888-1894
CMI-206 - A POTENT DUAL PLATELET-ACTIVATING-FACTOR ANTAGONIST AND 5-LIPOXYGENASE INHIBITOR
Authors: HUSSOIN MS CAI X SCANNELL RT YAEGER D KILLIAN DB ECKMAN J HWANG SB LIBERTINEGARAHAN L QIAN CG YEH CG IP S
Citation: Ms. Hussoin et al., CMI-206 - A POTENT DUAL PLATELET-ACTIVATING-FACTOR ANTAGONIST AND 5-LIPOXYGENASE INHIBITOR, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 643-648
A DUAL-ACTING INHIBITOR OF 5-LIPOXYGENASE AND PLATELET-ACTIVATING-FACTOR, CMI-392, REDUCES INFLAMMATION IN MOUSE EAR EDEMA MODELS
Authors: YEH CG ECKMAN J CAI XO IP SH
Citation: Cg. Yeh et al., A DUAL-ACTING INHIBITOR OF 5-LIPOXYGENASE AND PLATELET-ACTIVATING-FACTOR, CMI-392, REDUCES INFLAMMATION IN MOUSE EAR EDEMA MODELS, Journal of investigative dermatology, 104(4), 1995, pp. 649-649
Risultati: 1-7 |